Skip to main content

Find Clinical Trials

Home
Conditions
Mesonephroma

Clinical trial condition

Mesonephroma

Explore clinical trials studying Mesonephroma. Study availability and eligibility vary by location and protocol.

46 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Mesonephroma trial results

Completed

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

NCT00003883

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

University of Washington Medical Center Seattle, Washington, United States

View Trial Details

Completed

Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors

NCT00004157

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +94 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

NCT00014391

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +107 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors

NCT02375204

Conditions: Adenocarcinoma, Carcinoma, Childhood Teratoma, +22 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

Loma Linda University Medical Center Loma Linda, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View all 125 locations

View Trial Details

Active, Not Recruiting

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors

NCT05103631

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +38 more
Locations: Houston Methodist Hospital Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

NCT04377932

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, +32 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details